Response to Braillon
JNCI Cancer Spectr
.
2021 Jan 23;5(1):pkab005.
doi: 10.1093/jncics/pkab005.
eCollection 2021 Feb.
Authors
Bernardo Bonanni
1
,
Davide Serrano
1
,
Patrick Maisonneuve
2
,
Matteo Lazzeroni
1
,
Powel H Brown
3
,
Aliana Guerrieri-Gonzaga
1
,
Eva Szabo
4
Affiliations
1
Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, Milan, Italy.
2
Division of Epidemiology and Biostatistics, IEO European Institute of Oncology IRCCS, Milan, Italy.
3
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
4
Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
PMID:
33556158
PMCID:
PMC7853174
DOI:
10.1093/jncics/pkab005
No abstract available
Publication types
Research Support, N.I.H., Extramural
Comment
Grants and funding
HHSN261201200003I/CA/NCI NIH HHS/United States